Robert Bruce
Vorstandsvorsitzender bei Soricimed Biopharma, Inc.
Profil
Robert Bruce is currently the Chief Executive Officer at Soricimed Biopharma, Inc. since 2019.
Prior to this, he was the President & Chief Executive Officer at Beresford Box Co. Inc.
Aktive Positionen von Robert Bruce
| Unternehmen | Position | Beginn |
|---|---|---|
Soricimed Biopharma, Inc.
 Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Vorstandsvorsitzender | 17.07.2019 |
Ehemalige bekannte Positionen von Robert Bruce
| Unternehmen | Position | Ende |
|---|---|---|
Beresford Box Co. Inc.
 Beresford Box Co. Inc. Miscellaneous Commercial ServicesCommercial Services Beresford Box Co. Inc. designs and manufactures carton and packaging products. It produces folding paperboard-based packaging, specializing in high-quality, multi-colored printed cartons. The firm also provides other value-added services to its customers, including packaging design, in-house die and print-plate manufacturing, and commercial printing. The company was founded in 1964 and is headquartered in Waterloo, Canada. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Beresford Box Co. Inc.
Beresford Box Co. Inc. Miscellaneous Commercial ServicesCommercial Services Beresford Box Co. Inc. designs and manufactures carton and packaging products. It produces folding paperboard-based packaging, specializing in high-quality, multi-colored printed cartons. The firm also provides other value-added services to its customers, including packaging design, in-house die and print-plate manufacturing, and commercial printing. The company was founded in 1964 and is headquartered in Waterloo, Canada. | Commercial Services |
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Health Technology |
